Erratum: Erythrocyte-bound tissue pasminogen activator is neuroprotective in experimental traumatic (Brain Injury (2009) 26:9 (1585-1592) DOI: 10.1089/neu.2008.0720);Erythrocyte-bound tissue plasminogen activator is neuroprotective in experimental traumatic brain injury

Journal of Neurotrauma

Volumn 26, Issue 9, 2009, Pages 1585-1592

  Stein, Sherman C ^a   Ganguly, Kumkum ^b   Belfield, Caitlin M ^a   Xu, Xiangsheng ^a   Swanson, Edward W ^a   Chen, Xiao Han ^a   Browne, Kevin D ^a   Johnson, Victoria E ^a   Smith, Douglas H ^a   Lebold, David G ^a   Cines, Douglas B ^a   Muzykhantov, Vladimir R ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bloodbrain barrier; Microclots; Tissue plasminogen activator; Traumatic brain injury

Indexed keywords

ALTEPLASE; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX LESION; BRAIN HEMORRHAGE; CONTROLLED STUDY; DRUG BINDING; DRUG FORMULATION; ERYTHROCYTE; HISTOLOGY; NEUROPROTECTION; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; RAT; THROMBOSIS; TRAUMATIC BRAIN INJURY;

EID: 70450184289     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2008.0720-C     Document Type: Erratum

References (27)

1. Armstead, W.M., Ganguly, K., Kiessling, J.W., Higazi, A., Zaitsev, S., Cines, D., Bdeir, K., and Muzykantov, V.R. (2008). Rbc-Tpa helps prevent hypercapnic and hypotensive cerebrovascular impairment by inhibiting Erk Mapk upregulation after cerebral hypoxia=ischemia. Stroke 30, 165 [abstract].
2. Armstead, W.M., Nassar, T., Akkawi, S., Smith, D.H., Chen, X.H., Cines, D.B., and Higazi, A.A. (2006). Neutralizing the neurotoxic effects of exogenous and endogenous tPA. Nat. Neurosci. 9, 1150-1155.
3. Bdeir, K., Murciano, J.C., Tomaszewski, J., Koniaris, L., Martinez, J., Cines, D.B., Muzykantov, V.R., and Higazi, A.A. (2000). Urokinase mediates fibrinolysis in the pulmonary microvasculature. Blood 96, 1820-1826.
4. Danielyan, K., Ganguly, K., Ding, B.S., Atochin, D., Zaitsev, S., Murciano, J.C., Huang, P.L., Kasner, S.E., Cines, D.B., Muzykantov, V.R. (2008). Cerebrovascular thromboprophylaxis in mice by erythrocyte-coupled tissue-type plasminogen activator. Circulation 118, 1442-1449.
5. Fleck, R.A., Rao, L.V., Rapaport, S.I., and Varki, N. (1990). Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb. Res. 59, 421-437.
6. Ganguly, K., Goel, M.S., Krasik, T., Bdeir, K., Diamond, S.L., Cines, D.B., Muzykantov, V.R., and Murciano, J.C. (2006). Fibrin affinity of erythrocyte-coupled tissue-type plasminogen activators endures hemodynamic forces and enhances fibrinolysis in vivo. J. Pharmacol. Exp. Ther. 316, 1130-1136.
7. Ganguly, K., Krasik, T., Medinilla, S., Bdeir, K., Cines, D.B., Muzykantov, V.R., and Murciano, J.C. (2005). Blood clearance and activity of erythrocyte-coupled fibrinolytics. J. Pharmacol. Exp. Ther. 312, 1106-1113.
8. Ganguly, K., Murciano, J.C., Westrick, R., Leferovich, J., Cines, D.B., and Muzykantov, V.R. (2007). The glycocalyx protects erythrocyte-bound tissue-type plasminogen activator from enzymatic inhibition. J. Pharmacol. Exp. Ther. 321, 158-164.
9. Graham, D.I., and Adams, J.H. (1971). Ischaemic brain damage in fatal head injuries. Lancet 1, 265-266.
10. Graham, D.I., Ford, I., Adams, J.H., Doyle, D., Teasdale, G.M., Lawrence, A.E., and McLellan, D.R. (1989) Ischaemic brain damage is still common in fatal non-missile head injury. J. Neurol. Neurosurg. Psychiatry 52, 346-350. (Pubitemid 19075080)
11. Hlatky, R., Contant, C.F., Diaz-Marchan, P., Valadka, A.B., and Robertson, C.S. (2004). Significance of a reduced cerebral blood flow during the first 12 hours after traumatic brain injury. Neurocrit. Care 1, 69-83.
12. Hoshino, S., Kobayashi, S., and Nakazawa, S. (1996). Prolonged and extensive IgG immunoreactivity after severe fluidpercussion injury in rat brain. Brain Res. 711, 73-83.
13. Leoni, M.J., Chen, X.H., Mueller, A.L., Cheney, J., McIntosh, T.K., and Smith, D.H. (2000). Nps 1506 attenuates cognitive dysfunction and hippocampal neuron death following brain trauma in the rat. Exp. Neurol. 166, 442-449.
14. Lu, D., Mahmood, A., Goussev, A., Schallert, T., Qu, C., Zhang, Z.G., Li, Y., Lu, M., and Chopp, M. (2004). Atorvastatin reduction of intravascular thrombosis, increase in cerebral microvascular patency and integrity, and enhancement of spatial learning in rats subjected to traumatic brain injury. J. Neurosurg. 101, 813-821.
15. McIntosh, T.K., Vink, R., Noble, L., Yamakami, I., Fernyak, S., Soares, H., and Faden, A.L. (1989). Traumatic brain injury in the rat: Characterization of a lateral fluid- percussion model. Neuroscience 28, 233-244.
16. Murciano, J.C., Medinilla, S., Eslin, D., Atochina, E., Cines, D.B., and Muzykantov, V.R. (2003). Prophylactic fibrinolysis through selective dissolution of nascent clots by Tpa-carrying erythrocytes. Nat. Biotechnol. 21, 891-896.
17. Muzykantov, V.R., and Murciano, J.C. (1996). Attachment of antibody to biotinylated red blood cells: Immuno-red blood cells display high affinity to immobilized antigen and normal biodistribution in rats. Biotechnol. Appl. Biochem. 24, 41-45.
18. Narita, M., Bu, G., Herz, J., and Schwartz, A.L. (1995). Two receptor systems are involved in the plasma clearance of tissuetype plasminogen activator (T-Pa) in vivo. J. Clin. Invest. 96, 1164-1168.
19. Polavarapu, R., Gongora, M.C., Yi, H., Ranganthan, S., Lawrence, D.A., Strickland, D., and Yepes, M. (2007). Tissue-type plasminogen activator-mediated shedding of astrocytic lowdensity lipoprotein receptor-related protein increases the permeability of the neurovascular unit. Blood 109, 3270-3278.
20. Stein, S.C., Chen, X.-H., Sinson, G.P., Smith, D.H. (2002). Intravascular coagulation: A major secondary insult in nonfatal traumatic brain injury. J. Neurosurg. 97, 1373-1377.
21. Stein, S.C., Graham, D.I., Chen, X.H., and Smith, D.H. (2004). Association between intravascular microthrombosis and cerebral ischemia in traumatic brain injury. Neurosurgery 54, 687- 691; discussion 691.
22. Stein, S.C., and Smith, D.H. (2004). Coagulopathy in traumatic brain injury. Neurocritical Care 1, 479-488.
23. Stiefel, M.F., Udoetuk, J.D., Spiotta, A.M., Gracias, V., Goldberg, A., Maloney-Wilensky, E., Bloom, S., and Le Roux, P.D. (2006). Conventional neurocritical care and cerebral oxygenation after traumatic brain injury. J. Neurosurg. 105, 568-575.
24. Teasdale, G.M., and Graham, D.I. (1998). Craniocerebral trauma: Protection and retrieval of the neuronal population after injury. Neurosurgery 43, 723-737.
25. Yepes, M., and Lawrence, D.A. (2004). New functions for an old enzyme: Nonhemostatic roles for tissue-type plasminogen activator in the central nervous system. Exp. Biol. Med. (Maywood) 229, 1097-1104.
26. Yepes, M., Sandkvist, M., Moore, E.G., Bugge, T.H., Strickland, D.K., and Lawrence, D.A. (2003). Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J Clin. Invest. 112, 1533-1540.
27. Zaitsev, S., Danielyan, K., Murciano, J.C., Ganguly, K., Krasik, T., Taylor, R.P., Pincus, S., Jones, S., Cines, D.B., and Muzykantov, V. (2006). Human complement receptor type 1- directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis. Blood 108, 1895-1902.